Top News

Press Release | March 18, 2019
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that Pat Fogarty has joined the association as vice president, assistant general counsel and director of civil justice policy.
Press Release | March 11, 2019
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on the Trump Administration’s budget proposal to improve Medicare beneficiary access to breakthrough devices:
Press Release | March 7, 2019
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on introduction of bipartisan legislation (S. 692) – the Protect Medical Innovation Act – in the U.S.


March 20, 2019 | Virtual
March 20, 2019 | 10:30 - 11:30 am ET China FDA (NMPA) requires local type testing for the market approval of Class II and Class III medical device/IVD products. China local type testing is a... Read More
April 16, 2019 to April 17, 2019
| Washington, DC
How do you implement and measure the effectiveness of a complaint handling system covering a diverse set of possible products and problems? How are complaint files managed across multiple domestic... Read More
April 17, 2019 to April 18, 2019
| Washington, DC
During ​this ​workshop ​you'll ​establish ​a ​clear ​understanding ​how ​the ​regulatory ​affairs ​function ​is ​pivotal ​to ​every ​recall ​and ​every ​team ​decision. ​After ​partaking ​in ​... Read More
April 17, 2019 to April 18, 2019
| Washington, DC
AdvaMed’s Annual Payment Policy Conference brings together device manufacturers, hospitals, insurers, CMS, and Capitol Hill for in-depth discussions and analysis of the reimbursement and coverage... Read More
April 23, 2019 | Washington, DC
This workshop is considered "Day 0" to the 12th Annual FDA/AdvaMed Medical Devices and Diagnostics Statistical Issues Conference. Professionals often attend both the workshop and the conference. The... Read More

Industry News

Dthera™ Sciences (OTCQB: DTHR), a leading digital therapeutic company specialized in neurodegenerative diseases, is pleased to announce that it has entered into an exclusivity agreement with a company headquartered in Japan for development and commercialization rights to Dthera's lead product, DTHR-ALZ. The exclusivity agreement provides exclusive rights to the Japanese partner to perform feasibility studies in Japan and to negotiate a licensing agreement or other transaction for the Japanese...
Royal Philips has unveiled a new mixed reality concept to aid in minimally invasive surgeries, which it has developed with Microsoft, at the MWC 2019 mobile technology conference in Barcelona, Spain.
Digital Journal
SAN DIEGO, CA - iAssay® Inc., a privately held developer of the world's first open platform, point of care (POC) reader for remote medical diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application 13/074,209. The allowed patent includes 66 claims relating to multiple types of patient tests, wireless communications, plug-in modules, and user guides. The patent application is expected to issue in mid-2019...
AMSTERDAM, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced Azurion with FlexArm, to set a new standard for patient imaging and positioning flexibility for image-guided procedures.  During increasingly complex interventions, clinicians need to quickly and easily visualize critical anatomy and identify changes to the patient during the procedure. Azurion with FlexArm includes a set of innovations that makes it easier for the clinician...
RTI Surgical®
ALACHUA, Fla., – RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, and Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology, today announced that they have entered into a definitive agreement whereby RTI will acquire all outstanding equity interest of Paradigm Spine in a cash and stock transaction valued at up to $300 million, consisting of $150 million at closing plus potential future milestone payments. RTI believes this transaction...

Twitter Feed

March 18, 2019 - 4:00pm
“Patients are speaking up and holding lawmakers accountable to change policies that threaten their access to care.…
March 18, 2019 - 12:01pm
“Support for will ensure that American remains at the forefront of innovations that will…